THERESA BACH: Open Payments
NPI 1538682463 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,935 in 89 payments from 24 companies in 2025. Trend: 2023 $1,608 · 2024 $1,364 · 2025 $1,935
Food & beverage: $1,935
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 15 | $238 |
| ABBVIE INC. | 10 | $232 |
| SK Life Science, Inc. | 7 | $152 |
| PFIZER INC. | 11 | $145 |
| Teva Pharmaceuticals USA, Inc. | 5 | $141 |
| Eisai Inc. | 5 | $118 |
| CSL Behring | 4 | $103 |
| Lilly USA, LLC | 4 | $94 |
| TG Therapeutics, Inc. | 3 | $82 |
| Vanda Pharmaceuticals Inc. | 2 | $72 |
Products named: QULIPTA, Fintepla, NURTEC ODT, AUSTEDO XR, Leqembi, KISUNLA, Hizentra, BRIUMVI.
Industry payments across OK — which companies pay providers there.
